FEB TEST— 510(k) K830564

Substantially Equivalent

Wako Chemicals USA, Inc.

FDA 510(k) clearance K830564 for FEB TEST, Substantially Equivalent on 1983-03-29. Applicant: Wako Chemicals USA, Inc..

Clearance details

Applicant: Wako Chemicals USA, Inc.
Product code: Code CFM
Advisory panel: Clinical Chemistry
Date received: 1983-02-23
Decision date: 1983-03-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.